Literature DB >> 14291254

CONGENITAL THYROTOXICOSIS WITH HEPATOSPLENOMEGALY AND THROMBOCYTOPENIA, ASSOCIATED WITH ANIRIDIA AND DISLOCATED LENSES.

P E MORTIMER.   

Abstract

Entities:  

Keywords:  ABNORMALITIES; EYE DISEASES; HEPATOMEGALY; HYPERTHYROIDISM; IMMUNE SERUMS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; IRIS; JAUNDICE; LENS, CRYSTALLINE; LIVER DISEASES; MATERNAL-FETAL EXCHANGE; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS; SPLENOMEGALY; THROMBOPENIA; THYROID ANTAGONISTS

Mesh：

Substances：

Year:  1965        PMID： 14291254      PMCID： PMC1898589     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  7 in total

1.  CHILDHOOD THYROTOXICOSIS: A LONG-TERM PERSPECTIVE.

Authors:  K M SAXENA; J D CRAWFORD; N B TALBOT
Journal:  Br Med J       Date:  1964-11-07

2.  CONGENITAL THYROTOXICOSIS.

Authors:  D D ADAMS; J M LORD; H A STEVELY
Journal:  Lancet       Date:  1964-09-05       Impact factor: 79.321

3.  Congenital hyperthyroidism.

Authors:  G SCLARE
Journal:  Biol Neonat       Date:  1960-07

4.  Congenital thyrotoxicosis, hepatosplenomegaly and jaundice in two infants of exophthalmic mothers.

Authors:  M O SKELTON; B GANS
Journal:  Arch Dis Child       Date:  1955-10       Impact factor: 3.791

5.  Pretibial myxoedema with severe exophthalmos.

Authors:  G BLANSHARD
Journal:  Proc R Soc Med       Date:  1956-10

6.  Thyrotoxicosis in a newborn infant.

Authors:  B M MARGETTS
Journal:  Proc R Soc Med       Date:  1950-08

7.  A Foetus with Congenital Hereditary Graves's Disease.

Authors:  C White
Journal:  Proc R Soc Med       Date:  1912
  7 in total
  3 in total

1.  Congenital thyrotoxicois.

Authors:  B Samsamy; A K Jethwa; D Ferriman
Journal:  Proc R Soc Med       Date:  1970-06

Review 2.  Immunological diseases and pregnancy.

Authors:  J S Scott
Journal:  Br Med J       Date:  1966-06-25

3.  [Thrombocytopenic purpura secondary to hyperthyroidism].

Authors:  C Paulin; T Gonzalez
Journal:  Can Med Assoc J       Date:  1967-07-29       Impact factor: 8.262
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.